Cancer genetics and genomics

DEO researchers made seminal discoveries in the field, identifying genetic alterations of pivotal importance for personalized therapies (such as PML-RAR fusion and NPM mutation in leukemia). More recently, their research focus shifted to whole exome and whole genome sequencing-based approaches for the identification of novel genetic alterations and an in-depth description of genetic heterogeneity in tumors.

Cloning and functional characterization of the Acute Promyelocytic Leukaemia 15;17 translocation

Identification and functional characterization of NPM mutations in myeloid leukemias

Cloning of new translocations in hematological tumors (ATK-ALK, MYB-GATA1, ERC1-PDGFRB, FGFR1OP-RET, ABCA13-ITGBL1, BCL6- IGK, NUP98-HOXA9, FGFR-TIF1, ATV6- ABL1)

Identification of mutations of the coagulation pathway in brain metastases

Discovery of the Gabriele-DeVries syndrome, caused by germline mutations in the YY1 oncogene

Identification of molecular mechanisms linking double strand breaks formation and cancer translocations.

Our site uses cookies for better browsing usability and statistics on its use. If you want to learn more, or refuse consent to all or some cookies, click here.